A heteroaryloxyalkylheterocycle derivative of the Formula I:
R-(CH₂)n-O-R¹ I
is provided wherein:
R is a non-fused azole moiety;
n is 3, 4, 5, 6, 7 or 8; and
R¹ is a non-fused or fused, optionally substituted azole or furyl group, an optionally substituted amino group, or a phenyl group substituted by an optionally substituted imidazole or triazole group.
Such compounds have antipicornaviral activity.
Novel intermediates and processes are also described.
式 I 的杂芳基氧基烷基杂环衍
生物:
R-(CH₂)n-O-R¹ I
的杂芳氧基烷基杂环衍
生物,其中
R 是非融合的唑基;
n是3、4、5、6、7或8;以及
R¹ 是非融合或融合的任选取代的唑基或
呋喃基、任选取代的
氨基或被任选取代的
咪唑或三唑基取代的苯基。
此类化合物具有抗逆转录病毒活性。
此外,还介绍了新型中间体和工艺。